Laserfiche WebLink
LFR Levine-Fricke <br /> that the decontamination of equipment between samples is sufficient. The equipment <br /> blank samples are evaluated to confirm there is no cross contamination between <br /> sampling locations due to contamination on the sampling device. The sample containers <br /> for the equipment blank samples will be filled, labeled, and handled in the same <br /> manner as other field samples. One equipment blank sample will be collected for each <br /> analytical method for each sampling day. <br /> Laboratory Replicates: Laboratory replicates are used to measure the contribution of <br /> the analytical process to the overall imprecision of data. Laboratory replicates are <br /> employed for inorganic analyses, while MSDs are used to measure the analytical <br /> imprecision of organic methods. Laboratory replicates will be analyzed at the <br /> frequency of 1 per 20 samples. MSDs will be analyzed at the rate of 1 per 20 samples <br /> or 1 per sampling event, whichever is greater. <br /> Matrix Spikes: MSs are aliquots of field samples that are spiked with a known amount <br /> of standard. The unspiked and spiked aliquots are analyzed and the recovery of the <br /> spiked standard is determined. The recovery is used to approximate the analytical bias <br /> of the method. MSs will be analyzed at the rate of 1 per 20 samples or 1 per sampling <br /> day, whichever is greater. <br /> Method Blanks: Laboratory method blanks are used to assess laboratory contamination <br /> during performance of a method. Laboratory method blanks will be run at a minimum <br /> frequency of 1 per 20 samples or one per day. <br /> G2.2 Data Validation Procedures <br /> Data validation is performed on the project analytical data when the final analytical <br /> report is received by LFR. The data validation will include a data completeness review <br /> of each data package, and a review of QA/QC parameters as described in this appendix <br /> and as indicated in the National Functional Guidelines to ensure that all project <br /> analytical data are of reliable and comparable data quality. Specifically, the following <br /> QA/QC parameters will be reviewed: <br /> • holding times (to assess potential for degradation that will affect accuracy) <br /> • blanks (to assess contamination for all compounds) <br /> • MSs/MSDs or Laboratory Fortified Blanks (to assess accuracy of the methods and <br /> precision of the method relative to the specific sample matrix) <br /> • Internal Standards(to assess method accuracy and sensitivity) <br /> • Compound Quantitation Limits and MDLs (to assess sensitivity as compared to <br /> project-specific requirements) <br /> • Co-located samples RPDs (to assess precision of the method relative to field <br /> sampling techniques, the specific sample matrix, and representativeness of the <br /> sample aliquot to the area sampled) <br /> Page G-8 Final_RAP_Tracy_9.18.03(final).doaLFR <br />